In the Boardroom
Refine Search
Biotechnology
Oncology immunotherapy specialist Advaxis has appointed Shelonitda Rose as vice president of clinical development. 8 July 2015
Biotechnology
French biopharma company DBV Technologies has appointed Hugh Sampson as chief scientific officer. 26 June 2015
Biotechnology
Canadian clinical-stage oncology company ProNAi Therapeutics has appointed Barbara Klencke as chief development officer. 23 June 2015
Biotechnology
German clinical stage biopharma company Affimed NV has established operations in the USA. 23 June 2015
Biotechnology
Clinical-stage nanomedicines company BIND Therapeutics has appointed Andrew Hirsch as president and chief executive. 23 June 2015
Biotechnology
Switzerland-based ADC Therapeutics has appointed Chris Martin as its chief executive. 22 June 2015
Biotechnology
Regenerative medicine company Pasticell has recruited Aaron Chuang as chief scientific officer. 15 June 2015
Biotechnology
Independent US biotech company Amgen has appointed Corinne Le Goff as senior vice president and head of the European region. 1 June 2015
Biotechnology
UK biotech company Calchan has appointed Zahid Ali as chief scientific officer. 14 May 2015
Biotechnology
Microbiome-focused company Synthetic Biologics has appointed Maureen Early to the newly-created position of vice president, commercial. 7 May 2015
Biotechnology
Bill Aurora has been appointed vice president, medical affairs at Neurocrine Biosciences. 5 May 2015
Biotechnology
French biotech company Metabolium has appointed Khadidja Romari as chief operating officer and chief scientific director. 9 April 2015
Biotechnology
UK-based stem cell therapy company ReNeuron is making changes to its board and senior management as it prepares for the next phase of development. 2 April 2015
Biotechnology
Privately-owned UK biotech company Immunocore has appointed Christina Coughlin as chief medical officer. 1 April 2015
Biotechnology
Konstantinos (Kostas) Kosmatopoulos, a founder of anti-tumor immunotherapy specialist Vaxon Biotech, has become chief executive of the company. 30 March 2015
Biotechnology
Genome mapping specialist BioNano Genomics has appointed Terry Salyer as chief commercial officer. 26 March 2015
Biotechnology
Moderna Therapeutics, a specialist in messenger RNA therapeutics, has appointed Tal Zaks as chief medical officer from March 16. 16 March 2015
Biotechnology
Shares of US biotech firm ACADIA Pharmaceuticals plunged 22% to 34.70 in after-hours trading, after it announced that it now plans to submit a New Drug application for Nuplazid (pimavanserin) for the treatment of Parkinson’s disease in the second half of 2015. 12 March 2015
Biotechnology
Privately-held genomics and biotech company 23andMe has created a new therapeutics group, and appointed Richard Scheller to lead it. 12 March 2015
Biotechnology
French biotech company Adocia has created a US subsidiary, Adocia Incorporated, and appointed Simon Bruce and Stephen Daly. 6 March 2015
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze